Himalaya's Logo
  Search
  Health Help
 
   
 
Direct from Himalaya online.
 
 
Click to select your location.
 
   
Medicinal Range   Animal Health   Personal Care
   
Abana
Bonnisan
Bonnispaz
Bresol
Clarina
Confido
Cystone
Diabecon
Diakof
Diarex
Evecare
Gasex
Geriforte
Herbolax
Himcocid
Himcolin gel
Himcospaz
Himplasia
Koflet
Liv.52
Liv.52 DS
Lukol
Menosan
Mentat
Ophthacare
Oxitard
PartySmart
Picrolax
Pilex
PureHands
Purim
Renalka
Reosto
Rumalaya
Rumalaya forte
Rumalaya gel
Rumalaya liniment
Septilin
Serpina
Speman
Styplon
Talekt
Tentex forte
Tentex Royal
V-Gel
Appetonic Vet
Diarex Vet
Digyton
Erina
Galactin Vet
Geriforte Vet
HimCal
Himfertin Vet
HimROP Vet
Immunol
Inflamin Vet
Liv.52 Protec (Poultry)
Liv.52 Vet
Scavon
Speman Vet
Speman forte Vet
Tentex forte Vet (Poultry)
Acne-n-Pimple Cream
Anti-dandruff Hair Cream
Anti-dandruff Hair Oil
Anti-dandruff Shampoo
Anti-wrinkle Cream
Ayurslim Capsule
Baby Cream
Baby Lotion
Baby Powder
Cold Balm
Dental Cream
Diaper Rash Cream
Fairness Cream
Hair Loss Cream
Muscle & Joint Rub
Nourishing Baby Oil
Pain Balm
Sunscreen Lotion
Under Eye Cream
To view the clinical papers, your system needs the free Adobe Acrobat Reader, version 4 or later.
Click here to download.
 
Total no. of papers:261 - Clinical Papers:195, Experimental Papers:66
(Research papers based on Indications)
Highlighted journal names are international publications
 
In the prevention and treatment of viral hepatitis  
  1. Liver disorders during pregnancy and their management
    Arun Kumar Mitra, MBBS, DGO, MO, FICOG, FRCOG PhD (London) Former Professor and Head, Department of Obstetrics and Gynecology, Medical College. Calcutta. Pralhad S. Patki*, M.D., Head - Medical Services and Clinical Trials S.K. Mitra, M.D., Executive Director R&D Center, The Himalaya Drug Company, Bangalore, India. The Antiseptic 2008; 105 (4): 193-196

  2. Meta-analysis of 50 Phase III clinical trials in evaluation of efficacy and safety of Liv.52 in infective hepatitis
    Kolhapure, S.A., M.D., Senior Medical Advisor, and Mitra, S.K., M.D., Executive Director,Research and Technical Service, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update (2004): 12(2), 51-61.


  3. Comparative efficacy of five indigenous compound formulations in patients of acute viral hepatitis
    Dange, S.V., Lecturer, Patki, P.S., Reader, Pawar, S.S., Laboratory Technician, Phadke, S.A., Associate Professor and Shrotri, D.S., Professor and Head, Departments of Pharmacology and Microbiology, B.J. Medical College, Pune, India, Maharashtra Medical Journal (1989): (XXXVI), 5, 75.


  4. A trial with Liv.52 in infective hepatitis
    Vijaykumar, S. Karchi, X-ray Unit, Talkoti, Karnataka, Capsule (1988): Feb./Mar.,126.


  5. A study of serum glycolytic enzymes and serum B hepatitis in relation to Liv.52 therapy
    Patney, N.L. and Sumanbala Pachori, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, The Medicine and Surgery (1986): (XXVI), 4, 9.


  6. Liv.52 in infective hepatitis including precoma and coma
    Phadke, M.A. (Mrs.), Alka Datar and Nainesh M. Vora, B.J. Medical College and Sassoon General Hospitals, Pune, Maharashtra, Capsule (1984): (22), 8, 170.


  7. Studies with Liv.52 in the treatment of infective hepatitis, chronic active hepatitis and cirrhosis of the liver
    Mandal, J.N. and Roy, B.K., Department of Medicine, Medical College and Hospital, Calcutta, West Bengal, Probe (1983): (XXII), 4, 217.


  8. Antiviral activity of plant extract Liv.52 in mice experimentally infected with Semliki forest encephalitis virus
    Singh, V.K., George, C.X., Gupta, K.P. and Gupta, B.M., Central Drug Research Institute, Lucknow, Uttar Pradesh, Science and Culture (1983): 49, 354.


  9. Management of infective hepatitis
    Sreenivasa Rao, Y., I.S.&W.P. Hospital, Jamshedpur, Bihar, Probe (1983): (XXII), 2, 107.


  10. Role of Liv.52 in the treatment of infective hepatitis
    Chowdhury, A.B., Government Subdivisional Hospital, Karimganj, Cachar District, Assam, Capsule (1981): 3, 50.


  11. Infective hepatitis and Liv.52 drops
    Dinesh Chandra Misra, Primary Health Centre, Marteengaj, Azamgarh, Uttar Pradesh, Capsule (1981): 6, 122.


  12. Liv.52 therapy in acute infective hepatitis
    Kesarkar, A.S., S.V. Road, Goregaon West, Bombay, Maharashtra, Capsule (1981): 4, 74.


  13. Role of Liv.52 in the treatment of infective hepatitis
    Paritosh Biswas, Ashoke Nagar, (24 Parganas), Alipur, West Bengal, Capsule (1980): 4, 74.


  14. Study of Liv.52 therapy in infective hepatitis in children
    Shakuntala Saxena, (Mrs.), Ashok Kumar Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, Current Medical Practice (1980): (24), 5, 194.


  15. Viral hepatitis and Liv.52
    Uday Shankar Mandal, Giridih Block, Sirsia, Giridih, Bihar, Capsule (1980): 3, 50.


  16. Liv.52 in acute viral hepatitis – Results of a double-blind study
    Habibullah, C.M., Vinod Chandra, Padmanaban, C.G. and Ramakrishna, R., Department of Gastroenterology, Osmania General Hospital, Hyderabad, Andhra Pradesh, The Antiseptic (1978): (75), 8, 491.


  17. Effect of an indigenous preparation Liv.52 on hepatitis B antigen-carriage
    Kelkar, S.S., Grant Medical College, Bombay, Maharashtra, and Mahajan, R.K., Medical College, Aurangabad, Maharashtra, Probe (1978): (XVII), 2, 150.


  18. A preliminary report on the role of Liv.52, an indigenous drug in serum B hepatitis (Australia antigen positive) cases
    Patney, N.L. and Ashok Kumar, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, Probe (1978): (XVII), 2, 132.


  19. Clinical management of severe acute hepatic failure with special reference to Liv.52 therapy
    Sethi, J.P. and Madhulika Sharma, Department of Medicine, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, Probe (1978): (XVII), 2, 155.


  20. Liv.52 therapy in viral hepatitis (A clinico-biochemical study)
    Banerjee, L.K., Sahu, N.N., Ray, S.S. and Daljit Singh, BSF Base Hospital, Kadamtala, Siliguri, Darjeeling, West Bengal, Capsule (1977): 8, 170.


  21. A clinical study of infective hepatitis treated with Liv.52
    Ila V. Desai, Dudhia, M.V. and Gandhi, V.K., Sheth K.M. School of Postgraduate Medicine and Research, and Sheth V.S. General Hospital and Smt. N.H.L. Municipal Medical College, Ahmedabad, Gujarat, Indian Paediatrics (1977): 3, 197.


  22. Observations on the treatment of infective hepatitis with an indigenous drug Liv.52
    Singh, K.K., Department of Medicine, Singh, Y.K., Sinha, S.K., Department of Paediatrics, Sharma, V., Department of Medicine and Mishra, B.N., Department of Medicine, Darbhanga Medical College, Laheriasarai, Bihar, Indian Medical Journal (1977): 5, 69.


  23. Clinical trial of Liv.52 drops in infective hepatitis – A comparative study with broad spectrum antibiotics and corticosteroids
    Agrawal, V.K. and Meena Sareen, M.L.N. Medical College, Allahabad, Uttar Pradesh, Probe (1976): (XV), 2, 112.


  24. Viral hepatitis in children
    Chawhan, R.N., Talib, S.H., Talib, V.H., Sengupta, S.R. and Patil, S.D., Medical College, Aurangabad, Uttar Pradesh, The Medicine and Surgery (1976): 3, 9.


  25. Efficacy of an indigenous compound preparation Liv.52 in acute viral hepatitis – A double-blind study
    Sama, S.K., Krishnamurthy, L., Ramachandran, K. and Krishnan Lal, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Indian Journal of Medical Research (1976): 5, 738.


  26. A study of chronic hepatitis in northern India
    Singh, D.S., Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, Sama, S.K., Sir Ganga Ram Hospital, New Delhi and Singh, G., Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, Indian Journal of Medical Research (1976): (64), 12,1728.


  27. Viral hepatitis in children
    Reddi, Y.R., Sudhakar Rao, V., Rohini, K. and Kusuma, G., Institute of Child Health, Niloufer Hospital, Hyderabad, Andhra Pradesh, Indian Paediatrics (1975): (XII), 8, 659.


  28. Studies on Liv.52 in hepatic disorders – Part II
    Sharma, N.L., Lahori, U.C. and Mehta, S.K., King George Medical College, Lucknow, Uttar Pradesh, Probe (1975): (XIV), 2, 126.


  29. Liv.52 in infective hepatitis
    Bhandari, N.R. and Shashi Gupta (Miss.), Department of Paediatrics, Gandhi Medical College, Bhopal, Madhya Pradesh, Probe (1974): (XIV), 1, 68.


  30. Acute infectious hepatitis with fulminant hepatic failure – A study of 289 cases
    Deshpande, R.S., Kasturba Hospital for Infectious Diseases, Sane Guruji Marg, Bombay, Maharashtra, Probe (1974): (XIV), 1, 1.


  31. Trial of Liv.52 in infectious hepatitis in children in Goa
    Harish Mazumdar and Mira Mazumdar, Department of Paediatrics, Goa Medical College, Panaji, Goa, Probe (1974): (XIV), 1, 28.


  32. Studies with Liv.52 in infective hepatitis
    Jain, K.C., Khanijo, S.K. and Bisarya, B.N., Department of Medicine, S.S. Medical College, Rewa, Madhya Pradesh, Probe (1974): (XIV), 1, 64.


  33. Liv.52 therapy in infective hepatitis
    Khetarpal, S.K. and Veera Kumar, E., Department of Paediatrics, Medical College, Amritsar, Punjab, Probe (1974): (XIV), 1, 59.


  34. Trial of Liv.52 in infectious hepatitis in children in Goa
    Mazumdar, H. and Mazumdar, M., Department of Paediatrics, Goa Medical College, Panaji, Goa, Probe (1974): (XIV), 1, 82.


  35. Liv.52 in viral hepatitis with special reference to its use in precoma and coma
    Mitra, D.K., Ashrafuddin, S. and Talib, S.H., Department of Medicine, Medical College, Aurangabad, Maharashtra, Probe (1974): (XIV), 1, 14.


  36. Role of Liv.52 and steroids in the management of viral hepatitis in children
    Reddi, Y.R., Rohini, K., Kusuma, G. and Sudhakar Rao, V., Osmania Medical College, Institute of Child Health and Niloufer Hospital, Hyderabad, Andhra Pradesh, Probe (1974): (XIV), 1, 35.


  37. Studies on Liv.52 in hepatic disorders – Part I
    Sharma, N.L., Lahori, U.C. and Mehta, S.K., King George Medical College, Lucknow, Uttar Pradesh, Probe (1974): (XIV), 1, 54.


  38. Observations on the therapy of acute infectious hepatitis with Liv.52
    Shishupal Ram and Kumar, P., Liver Research Unit, Hospital for Children, Patna Medical College Hospital, Patna, Bihar, Probe (1974): (XIV), 1, 66.


  39. Studies on 222 cases of acute infective hepatitis during an epidemic
    Sinha, B.B., Kurzi Holy Family Hospital, Patna, Bihar, Probe (1974): (XIII), 3, 130.


  40. Liv.52 trial in infective hepatitis
    Mehrotra, M.P.,and Dineshchandra Mathur, Research Fellow, S.N. Medical College, Agra, Uttar Pradesh, The Antiseptic (1973): (70), 2, 114.


  41. Liv.52 in the treatment of acute infective hepatitis
    Sarkar, M.K., Burn and Co., Durgapur, Burdwan, Rajasthan, The Indian Practitioner (1973): 8, 395.


  42. Clinico-biochemical study of infective hepatitis with special reference to Liv.52 therapy
    Dave, D.S., Rajput, V.J. and Gupta, M.R., Department of Paediatrics, G.R. Medical College, Gwalior, Madhya Pradesh, Probe (1972): (XI), 4, 214.


  43. Therapeutic effects of Liv.52 in post-necrotic hepatitis
    Gupta, S., Khatri, R.L. and Srivastava, G., Maulana Azad Medical College, New Delhi, Probe (1972): (XII), 1, 15.


  44. Therapy of infectious hepatitis and other liver disorders
    Gupta, S., Khatri, R.L. and Srivastava, G., Maulana Azad Medical College, New Delhi, Probe (1972): (XI), 2, 93.


  45. Liv.52 therapy in viral hepatitis
    Patel, G.T., Mruthyunjayanna, B.P., Seetharam, T.D. and Channe Gowda, A.C., Medicine Unit, Victoria Hospital and Bangalore Medical College, Bangalore, Karnataka, Probe (1972): (XI), 2, 112.


  46. Chronic active hepatitis (A preliminary observation of 10 cases)
    Dasgupta, M. and Mukerjee, A.B., Department of Medicine, R.K. Mission Seva Pratisthan, Calcutta, West Bengal, Journal of Indian Medical Profession (1971): 18, 8097.


  47. Infectious hepatitis – Study of 100 cases
    Deshpande, R.S., Kasturba City Fever Hospital, Bombay, Maharashtra, Shantilal C. Sheth, Kasturba City Fever Hospital and Emeritus Director Professor of Paediatrics, Topiwala National Medical College and Nair Hospital, Bombay, Maharashtra, and Joy Kutty, M.D., Research Scholar, Bombay, Maharashtra, Current Medical Practice (1971): 6, 810.


  48. Some observations on Liv.52 in the treatment of infective hepatitis and cirrhosis of liver
    Lala Surajnandan Prasad, Department of Paediatrics, Patna University, and Kaleshwer Prasad, Department of Paediatrics, Children’s Hospital, Patna Medical College and Hospital, Patna, Bihar, Probe (1971): (X), 3, 114.


  49. Liv.52 studies in acute hepatitis
    Ramalingam, V., Sundarvalli, N. and Balagopal Raju, V., Institute of Child Health and Hospital for Children, Egmore, Madras, Tamil Nadu, Indian Paediatrics (1971): 12, 839.


  50. Infective hepatitis – Survey and study of 110 cases
    Doddagoudar, M.B., Karnatak Medical College, Hubli, Karnataka, Probe (1970): (IX), 3, 122.


  51. Treatment of viral hepatitis by an indigenous drug – Liv.52
    Mukerjee, A.B., Calcutta National Medical College and Hospitals, and Department of Medicine,Dasgupta, M., Ramakrishna Mission Seva Pratishthan, Calcutta, West Bengal, The Indian Practitioner (1970): June, 357.


  52. Liv.52 in infective hepatitis
    Jaffari, S.M.H. and Shyam Raj, Fever Hospital, Hyderabad, Andhra Pradesh, The Antiseptic (1969): 5, 353.


  53. Role of various types of treatment in infectious hepatitis
    Major Arora, J.K., MH Lebong, Darjeeling, West Bengal, Armed Forces Medical Journal (1969): (XXV), 3, 362.


  54. Studies with Liv.52 therapy in infective hepatitis
    Sule, C.R., Pai, V.R., Damania, R.F. and Joshi, V.S. (Miss.), Medicine Unit, Sasoon General Hospitals and B.J. Medical College, Poona, Maharashtra, Journal of Indian Medical Profession (1968): 14, 6391.


  55. Preliminary observations on the role of Liv.52 in infective-hepatitis with persistent jaundice
    Rath, B.B., Department of Medicine, Sengupta, S.N., Department of Medicine, and Bose, S.N., Department of Biochemistry, Bankura Sammilani Medical College and Hospital, Bankura, West Bengal, Capsule (Undated): (XV), 8, 170.
   
In the prevention and treatment of alcoholic liver disease
  1. Liv.52 regulates ethanol induced PPARγ and TNF-α expression in HepG2 cells
    Shankar K. Mitra, Sandeep Ravi Varma, Ashok Godavarthi, Krishna S. Nandakumar, R&D Center, The Himalaya Drug Company, Bangalore, Karnataka, Molecular Cell Biochemistry (2008): 315, 9.

  2. Role of Liv.52 - A herbal formulation on 14C-Ethanol metabolism and 14C-Acetaldehyde accumulation in rat liver
    Singh, B., Department of Nuclear Medicine, PGIMER, Chandigarh, Punjab, and Dhawan, D., Department of Biophysics, Panjab University, Chandigarh, Punjab, Indian Journal of Nuclear Medicine (2000): (15), 1, 27.


  3. Hepatoprotective effects of Liv.52 on ethanol-induced liver damage in rats
    Rajat Sandhir and Gill, K.D., Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, Haryana, Indian Journal of Experimental Biology (1999): (37), August, 762.


  4. Effect of the hepatoprotective drug Liv.52 on liver damage
    M. Kalab, T. Krechler Internal Clinic of the Medical Faculty of the Charles University in Prague and The Military Faculty Hospital in Prague, The Journal of Czech Physicians (1997): (136), 24, 758-760.


  5. Bioassay for evaluation of the hepatoprotective effect of Liv.52, a polyherbal formulation, on ethanol metabolism in chronic alcohol – Exposed rats
    Chauhan, B.L., Mohan, A.R., Kulkarni, R.D. and Mitra, S.K., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Indian Journal of Pharmacology (1994): (26), 117.


  6. Protective effect of Liv.52 on alcohol-induced fetotoxicity
    Gopumadhavan, S., Jagadeesh, S., Chauhan, B.L. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Alcoholism: Clinical and Experimental Research (1993): (17), 5, 1089.


  7. Alcoholic liver disease – The possibility of ayurvedic therapy
    Kulkarni, R.D., Clinical Pharmacology, Bombay, Maharashtra, The Journal of General Medicine (1992): (4), 2, 11.


  8. Alcohol hangover and Liv.52
    Chauhan, B.L. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, European Journal of Clinical Pharmacology (1991): 40, 187.


  9. Effect of Liv.52, a herbal preparation, on absorption and metabolism of ethanol in humans
    Chauhan, B.L. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, European Journal of Clinical Pharmacology (1991): 40, 189.


  10. Dose response of ethanol after chronic administration of alcohol and effect of Liv.52 on blood, liver ethanol and acetaldehyde levels in rats
    Chauhan, B.L. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, European Journal of Pharmacology (1990): (183), 5, 1864.


  11. Blood, urine ethanol and acetaldehyde levels from six different alcoholic beverages and effect of Liv.52
    Kulkarni, R.D. and Chauhan, B.L., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, European Journal of Pharmacology (1990): (183), 5, 1865.


  12. Addiction and industry
    Alan De Sousa, J.J. Hospital and Grant Medical College, Bombay, Maharashtra, Industrial Psychiatry Journal (1989): 2, 1, 5.


  13. Liv.52 in alcoholism
    Alan De Souza, Prakash Gangdev, Ashok Sinorawala and Manoj Agrawal, Department of Psychiatry, Grant Medical College and J.J. Hospital, Bombay, Maharashtra, Journal of Communication Psychiatry (1989): (12), Jan./Mar., 23.


  14. Injurious effects of ethyl alcohol on liver function and protective effect of Liv.52
    Doshi, B.S. and Kulkarni, R.D., The Indian Practitioner (1987): Nov., 965.


  15. The mechanism of cellular damage in alcoholic liver disease and the protective action of Liv.52
    Soman, R.N., Bhatia General Hospital, Tardeo, Bombay, Maharashtra, Probe (1983): (XXII), 3, 164.


  16. Effect of ethanol on liver function and its relation to hangover: Protective effect of Liv.52
    Kulkarni, R.D., Grant Medical College, Bombay, Maharashtra, Indian Drugs (1980): 11, 363.


  17. Electron microscopic study of the liver after prolonged use of alcohol
    Prasad, G.C., Department of Shalya Shalakya and Surgical Research Laboratory, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Probe (1980): (XIX), 3, 179.


  18. Effect of Liv.52 on different bio-chemical parameters in alcoholic cirrhosis
    Dubey, G.P., Aruna Agrawal and Dixit, S.P., Department of Basic Principles, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, The Antiseptic (1977): (91), 6, 205.


  19. Effect of an indigenous drug Liv.52 against alcohol-induced hepatic damage – A biochemical study
    Subbarao, V.V., Department of Physiology and Biochemistry, S.N. Medical College, Jodhpur, Rajasthan, Probe (1976): (XV), 4, 235.


  20. Prolonged moderate alcohol intake and liver function
    Damle, V.B., L.T.M.G. Hospital and L.T.M. College, Sion, and Kulkarni, R.D., Grant Medical College and J.J. Group of Hospitals, Bombay, Maharashtra, Probe (1973): (XIII), 1, 31.


  21. Effect of Liv.52 on growth and alcohol-induced hepatic dysfunction in rats
    Kale, A.K., Kulkarni, S.D. (Mrs.), Joglekar, G.V. and Balwani, J.H., B.J. Medical College, Poona, Maharashtra, Current Medical Practice (1966): (10), 240.
   
In the prevention and treatment of pre-cirrhotic conditions and early cirrhosis  
  1. The efficacy of Liv-52 on liver cirrhotic patients: A randomized, double-blind, placebo-controlled first approach
    H. Fallah Huseinia*, S.M. Alavianb, R. Heshmatc, M.R. Heydarid, K. Abolmaalie
    a Department of Pharmacology, Institute of Medicinal Plants, No. 97, Bozorgmehr St., Ghods St., Enghelab Ave., Tehran, Iran. b Baqiatallah University of Medical Sciences, Tehran Hepatitis Center, Tehran, Iran.
    c Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran.
    d Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran.
    e Baqiatallah University of Medical Sciences, Tehran, Iran     Phytomedicine 12(2005) 619-624.

  2. A novel mechanism of action prevents ethanol-induced injury – Liv.52 profile of an herbal remedy
    Chauhan, B.L. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Drug News & Perspectives (1993): (6), 9, 662.


  3. Liv.52 in the management of various hepatic disorders – A study of 53 cases
    Bharadia, G.R., Kukade, A.L., Kulkarni, A.S. and Rathod, I.M., Vivekanand Hospital, Latur, Maharastra, Probe (1986): (XXV), 3, 277.


  4. Role of Liv.52 in Indian childhood cirrhosis, with special reference to its effect on alpha-I-antitrypsin levels
    Nawal Kishore Agrawal, Prasad, R., Manju Sharma and Sharma, B.B., S.N. Medical College and Hospital, Agra, Uttar Pradesh, Asian Medical Journal (1982): 9, 647.


  5. Role of Liv.52 in management of Indian childhood cirrhosis
    Shakuntala Saxena (Mrs.), Ashok Kumar Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, Current Medical Practice. (1980): (24), 7, 269.


  6. Role of Liv.52 in hepatitis and cirrhosis of the liver
    Mallik K.K. and Pal, M.B., Department of Medicine, Institute of Postgraduate Medical Education and Research, Calcutta, West Bengal, Current Medical Practice (1979): 23, 5.


  7. Liv.52 in the treatment of cirrhosis of liver – Certain observations
    Singh, K.K., Department of Medicine, Singh, Y.K., Dubey, K.M., Department of Biochemistry, Sharma, V., Department of Medicine, and Mishra, B.N., Darbhanga Medical College, Laheriasarai, Bihar, The Antiseptic (1979): (76), 7, 393.


  8. A study of therapeutic actions of Liv.52 on various stages, severity, and activity of portal cirrhosis and infective hepatitis
    Sinha, P.K., B.R.D. Medical College, Gorakhpur, Uttar Pradesh, Ashok Kumar and Patney, N.L., Post-graduate Department of Medicine, S.N. Medical College, Uttar Pradesh, Probe (1979): (XVIII), 3, 157.


  9. Study of Liv.52 therapy in cases of Indian childhood cirrhosis and other liver disorders
    Mehar Singh and Agrawal, V.K., S.N. Children’s Hospital, M.L.N. Medical College, Allahabad, Uttar Pradesh, Probe (1978): (XVII), 2, 169.


  10. Management of steatorrhoea of cirrhosis of the liver by an indigenous drug – Liv.52
    Patney, N.L., Jasuja, R.K. and Ashok Kumar, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, Probe (1976): (XV), 3, 164.


  11. Liv.52 – A clinico-biochemical trial in hepatic cirrhosis
    Mehrotra, M.P. and Tandan, S., S.N. Medical College, Agra, Uttar Pradesh, Current Medical Practice (1973): (17), 4, 185.


  12. Hepatic cirrhosis in the tropics
    Mukerjee, A.B., Calcutta National Medical College and Hospital, Calcutta, West Bengal, Dasgupta, M., Resident University of Tennessee College of Medicine, USA, and Sarkar, S.K., N R Sarkar Medical College, Calcutta, West Bengal, Probe (1973): (XII), 2, 91.


  13. Liv.52 – A new therapeutic agent in the management of steatorrhoea of cirrhosis of the liver
    Patney, N.L., Jasuja, R.K. and Ashok Kumar, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, Journal of Research in Indian Medicine (1973): 3, 28.


  14. Long-term studies on the therapy of hepatic damage and cirrhosis of liver
    Lala Surajnandan Prasad, Patna Medical College and Prince of Wales Hospital, Patna, Bihar Sinha, K.N., Prince of Wales Hospital, Patna, Bihar, Devendra Tripathy and Prasad, K., Research Scholar, Patna, Bihar, Current Medical Practice (1971): (15), 12, 1071.


  15. Cirrhosis of liver – Results of treatment with an indigenous drug: Liv.52
    Mukerjee, A.B. and Dasgupta, M., Department of Medicine, Ramakrishna Mission Seva Pratishthan, Calcutta, West Bengal, Journal of Indian Medical Profession (1971): 17, 7853.


  16. B.S.P. test in the evaluation of therapy in hepatic cirrhosis by an indigenous drug – Liv.52
    Dasgupta, M., Ramakrishna Mission Seva Pratishthan, Calcutta, West Bengal,and Mukerjee, A.B., Calcutta National Medical College and Hospitals, Calcutta, West Bengal, The Indian Practitioner (1970): 12, 739.


  17. Cirrhosis of liver
    Shantilal C. Sheth and Tibrewala, N.S., Bharat Medical Journal (1970): (2), 2, 130.


  18. Liv.52 – Infantile cirrhosis
    Paulose, P.M., The Indian Practitioner (1963): 6, 516.


  19. Clinical and histopathological evaluation of Liv.52 in cirrhosis in liver
    Vyas, K.J., General Hospital, Junagadh, Gujarat, Probe (1963): 2, 66.


  20. Treatment of hepatopathy in children with a combination of capparis spinosa and other Indian indigenous drugs
    Vyas, K.J., Children Ward, General Hospital, Junagadh, Gujarat, Medical Digest (1961): (29), 3, 105.


  21. Therapy of cirrhosis of liver and liver damage with indigenous drugs – Experimental and clinical studies
    Shantilal C. Sheth, Basil J. Northover, Tibrewala, N.S., Warerkar, U.R. and Karande, V.S. B.Y.L. Nair Hosptial and Topiwala National Medical College and the Christian Medical College and Hospital, Vellore, Tamil Nadu, Indian Journal of Paediatrics (1960): 27, 204.


  22. Liv.52 therapy in cirrhosis of liver in children
    Vyas, K.J., Indian Journal of Child Health (1960): 5, 244.


  23. Treatment of infantile cirrhosis with an indigenous preparation
    Vyas, K.J., Children Hospital, Sir T. Hospital, Bhavnagar, Gujarat, The Indian Practitioner (1958): (XI), 1, 107.


  24. Some clinical observations on the use of Liv.52 (An indigenous drug) in cases of cirrhosis of liver in children
    Mathur, P.S., Hamidia Hospital, Bhopal, Madhya Pradesh, Current Medical Practice (1957): 5, 107.
   
In the prevention and treatment of protein energy malnutrition  
  1. Malnourished children and Liv.52
    Renu Patel and Pereira, L., Department of Paediatrics, J.J. Group of Hospitals, Bombay, Maharashtra, The Indian Practitioner (1993): (XLVI), 7, 523.


  2. A study of the effect of Liv.52 syrup on malnourished children in rural area
    Syed Fiaz Peeran, District Health Officer, Madurai District, Manivasagam, M. and Unnamalai, R., Primary Health Centre, Ammayanaickanur, Madurai District, Tamil Nadu, Capsule (1982): 4, 74.


  3. Effect of Liv.52 therapy in malnourished children
    Shakuntala Saxena, (Mrs.), Ashok Kumar Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, Current Medical Practice (1980): 6, 229.


  4. Role of Liv.52 in children with malnutrition
    Phadke, M.A. (Mrs.), Arkadi, D.P., Sainani, G.S., Upgraded Department of Medicine, and Phadke, M.V., Department of Medicine and Department of Paediatrics, B.J. Medical College and Sassoon General Hospitals, Pune, Maharashtra, Probe (1978): (XVII), 2, 160.


  5. A study of the growth-promoting effect of Liv.52 in malnutrition (A clinical trial)
    Shrivastava, D.K., Singwekar, A.G., Thawaani, Y.P. and Tiwari, A.K., Department of Child Health, G.R. Medical College and K.R. Hospital, Gwalior, Madhya Pradesh, Probe (1978): (XVII), 4, 305.


  6. Role of Liv.52 in the treatment of malabsorption syndrome
    Tripathi, S.N., Misra, A.K., Upadhyaya, K.N., Dixit, O.P. and Srivastava, S.K., Department of Kayachikitsa, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Journal of Research in Indian Medicine, Yoga and Homeopathy (1977): 1, 49.


  7. Management of protein-calorie malnutrition with Liv.52 as an adjuvant
    Bhandari, B., R.N.T. Medical College and General Hospital, Udaipur, Rajasthan, Probe (1976): (XV), 4, 245.


  8. Liv.52 in sub-optimal growth
    Desai, A.B. and Shah, A.A., Department of Paediatrics, B.J. Medical College, Ahmedabad, Gujarat, Probe (1976): (XV), 4, 247.


  9. A clinical study of the effect of Liv.52 on the growth pattern of normal and malnourished children in a rural area – 310 cases
    Reddy, Y.R., Sulochana, K.S. and Mathur, Y.C., Niloufer Hospital, Hyderabad, Andhra Pradesh, Paediatric Clinics of India (1975): 3, 157.


  10. Liv.52 therapy in cases of malnutrition, infective hepatitis, infantile cirrhosis and anorexia (A clinico-pathological study)
    Dayal, R.S., Kalra, K., Mital, V.P. and Rajiv Sharan, S.N. Medical College, Agra, Uttar Pradesh, The Antiseptic (1974): (71), 2, 89.


  11. Liv.52 in malnutrition and sub-optimal growth
    Desai, A.B. (Mrs.), B.J. Medical College and Civil Hospital, Ahmedabad, Gujarat, Probe (1974): (XIII), 4, 167.


  12. Clinico-biochemical trials with an indigenous drug: Liv.52 – In malnutrition
    Mathur, P.S., Chandra, I. and Khan, M.A., Department of Paediatrics, M.G.M. Medical College, Indore, Madhya Pradesh, Probe (1974): (XIII), 3, 136.


  13. Clinical evaluation of Liv.52 therapy in malnutrition during infancy and childhood
    Dave, D.S., Rajput, V.J., Gupta, M.R., Jain, V.K. and Lavangikar, U. (Miss.), Department of Paediatrics, G.R. Medical College, Gwalior, Madhya Pradesh, Probe (1973): (XIII), 1, 1.


  14. Clinical trial of Liv.52 drops
    Mangalam, S. and Sunderavalli, N., Government Royapettah Hospital, Bombay, Maharashtra, Mediscope (1973): (XVI), 1, 23.


  15. The effect of Liv.52 on the pattern of weight-gain in children with marasmus and other degrees of malnutrition as compared with that of non-virilizing androgens
    Tirumala Rao, P., Aziz Mohd. Khan and Anjaiah, K., Department of Paediatrics, Gandhi Hospital, Secunderabad, Andhra Pradesh, Probe (1973): (XII), 2, 78.


  16. Malnutrition – Hepatic function and Liv.52 therapy
    Khetarpal, S.K., Leela Ramkumar and Ram Lubhaya, Department of Paediatrics, Medical College, Patiala, Punjab, Current Medical Practice (1972): (16), 11, 481.


  17. Comparative trial of Liv.52 and orabolin in marasmus
    Tirumala Rao, P., Aziz Mohd. Khan and Anjaiah, K., Secunderabad, Andhra Pradesh, Indian Journal of Paediatrics (1972): (39), 227.


  18. Liv.52 therapy in hypoproteinaemia
    Vasant R. Pai, Borgave, M.A., Sule, C.R., Kale, S.S. and Sudam Kale, Department of Medicine, B.J. Medical College, Sassoon Hospitals, Poona, Maharashtra, Journal of Indian Medical Profession (1972): 6, 8447.


  19. A clinico-pathological study of hepatomegaly with special reference to Liv.52 therapy
    Dayal, R.S., Kalra, K., Rajvanshi, V.S. and Baheti, P.C., S.N. Medical College, Agra, Uttar Pradesh, Journal of Indian Medical Profession (1970): (17), 9, 7768.


  20. Effect of Liv.52 on growing rats under the influence of corticosteroids
    Kulkarni, S.D. and Joglekar, G.V., Department of Pharmacology, B.J. Medical College, Poona, Maharashtra, The Indian Practitioner (1970): 5, 299.
   
In the prevention and treatment of loss of appetite  
  1. Clinical Evaluation and safety of Liv.52 Drops in the management of loss of appetite in children: A subset analysis
    Subhasish S. Bhattacharya,Department of Pediatrics, Medical College, Kolkata, India Pralhad S. Patki, M.D., Head - Medical Services and Clinical Trials, S.K. Mitra, M.D., Executive Director,R&D Center, The Himalaya Drug Company, Bangalore-562 123, India. The Antiseptic 2008; 105(3): 139-141

  2. Evaluation of efficacy and safety of Liv.52 tablets & Liv.52 drops in anorexia in children.
    Subhasish Bhattacharya, Department of Pediatrics, Medical College, Kolkatta Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bangalore, India. Capsule (2004): (XLIV), 1, 1.

  3. Effect of Liv.52 on fenfluramine-induced anorexia
    Gokhale, M.S., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, Probe (1990): (XXIX), 3, 186.


  4. Liv.52 in anorexia of varying aetiology
    Dharmalingam, A. and Chandrasekaran, K., Bhavani, Periyar District, Tamilnadu, Probe (1985): (XXIV), 4, 233.


  5. Liv.52 in post-cholecystectomy dyspepsia
    Misgar, M.S., Karihaloo, Mir Nazir Ahmed, Sethi, S.K. and Mohd. Yousuf Wani, Department of Surgery, Government Medical College, Srinagar, Jammu and Kashmir, Probe (1984): (XXIII), 3, 150.


  6. Infant feeding problems and the role of Liv.52
    Dharam B. Sharma and Lahori, U.C., Children’s Hospital, Medical College, Jammu, Jammu and Kashmir, Probe (1980): 4, 275.


  7. Biological rhythms and medicine
    Kulkarni, R.D., Grant Medical College, Bombay, Maharashtra, Current Medical Practice (1980): (24), 8, 305.


  8. The anabolic activity of Liv.52
    Aslam, M. and Aslam, S., Department of Obstetrician and Gynaecology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, Probe (1979): (XVIII), 2, 74.


  9. Effect of Liv.52 on anorexia of varied aetiology
    Anil Mohan and Reddy S.V.R., Institute of Paediatrics and Child Health, Andhra Medical College, Visakhapatnam, Andhra Pradesh, Probe (1975): (XIV), 2, 136.


  10. Observation on the anabolic effects of Liv.52 in burns
    Sinha, R.N., Singh, Y. and Madan, P., Department of Plastic Surgery, Patna Medical College Hospitals, Patna, Bihar, Indian Journal of Plastic Surgery (1972): (5), 1, 26.


  11. Effect of Liv.52 in anorexia of hookworm disease (A preliminary study)
    Dutta, J.K., Balak Ram Hospital, Delhi, Probe (1971): (XI), 1, 26.


  12. Liv.52 in anorexia in paediatric practice
    Saxena, S., S.M.S. Medical College, Jaipur, Rajasthan, Current Medical Practice (1971): 15, 580.


  13. Liv.52 in anorexia in children
    Sesha Chari, K.R., Kakatiya Medical College, Warangal, Andhra Pradesh, Bharat Medical Journal (1971): 2, 181.


  14. Study on Liv.52 – An indigenous anabolic compound
    Sunita D. Kulkarni, Kulkarni, D.S., Vasantgadkar, P.S. and Joglekar, G.V., Department of Pharmacology, Physiology and Anatomy, B.J. Medical College, Poona, Maharashtra, The Indian Practitioner (1971): 2, 145.


  15. Therapy of anorexia with Liv.52
    Indira Bai, K., Mallikarjuna Rao, V.P.R. and Subba Rao, K.V., S.V. Medical College, and S.V.R.R. Hospital, Tirupati, Andhra Pradesh, The Antiseptic (1970): 67, 615.


  16. Treatment of anorexia by Liv.52
    Mukherji, J.P., Moti Lal Nehru Hospital, Jabalpur Cantonment, Madhya Pradesh, Probe (1969): (IX), 1, 25.


  17. Mechanism of anorexia and effect of Liv.52 on food intake
    Athavale, V.B., Lokmanya Tilak Municipal General Hospital, Sion, Bombay, Maharashtra, Probe (1966): 6, 12.


  18. Anabolic effect of Liv.52
    Damle, V.B. and Deshpande, K.J., Bombay, Maharashtra, Port Trust, Bombay, Maharashtra, The Indian Practitioner (1966): 19, 357.


  19. Therapy of anorexia with Liv.52
    Shantilal C. Sheth, Tibrewala, N.S., Warerkar, U.R. and Karande, V.S., B.Y.L. Nair Hospital and Topiwala National Medical College, Bombay, Maharashtra, Probe (1963): 4, 137.
   
In the prevention and treatment of radiation and chemotherapy-induced liver damage  
  1. Hepatoprotective effect of Liv.52 and kumaryasava on carbon tetrachloride-induced hepatic damage in rats
    Meena Kataria and Singh, L.N., Division of Biochemistry and Food Science, Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, Indian Journal of Experimental Biology (1997): (35), June, 655.


  2. Protective effect of Liv.52 and Liv.100, ayurvedic formulations on lipid peroxidation in rat liver homogenate – An in vitro study
    Suja, V., Latha Sharmila, S. and Shyamala Devi, C.S., Department of Biochemistry, University of Madras, Tamil Nadu, Guindy Campus, Madras, Tamil Nadu, Indian Journal of Experimental Biology (1997): (35), Jan., 50.


  3. Prevention of mercuric chloride-induced cerebellar damage in mice with a multiherbal hepatic drug results and possibilities
    Varghese, J., Shrilakshmi, K. and Rathore, H.S., School of Studies in Zoology and Chemistry, Vikram University, Ujjain, Madhya Pradesh, Indian Journal of Occupational Health (1997): (40), 1, 1.


  4. Radioresponse of leucocytes in peripheral blood of mice against gamma irradiation and their protection by Liv.52
    Daga, S.S., Jain, V.K. and Goyal, P.K., Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, Rajasthan, Probe (1995): (XXXIV), 3, 222.


  5. Liv.52 pretreatment inhibits the radiation-induced lipid peroxidation in mouse liver
    Ganapathi, N.G. and Ganesh Chandra Jagetia, Department of Radiobiology, Kasturba Medical College, Manipal, Karnataka, Current Science (1995): (69), 7, 601.


  6. Hepatoprotective effects of Liv.52 and its indirect influence on the regulation of thyroid hormones in rat liver toxicity-induced by carbon tetrachloride
    Dhawan, D. and Goel, A., Department of Biophysics, Punjab University, Chandigarh, Punjab, Research in Experimental Medicine (1994): 194, 203.


  7. Hepatoprotective role of Liv.52 in toxic conditions of Liver – An ultrastructural study
    Dhawan, D., Goel, A. and Sharma, M.L., Department of Biophysics, Punjab University, Chandigarh, Haryana, IECM (1994): 17-22, 1243.


  8. Herbomineral preparations as adjuvants to chemotherapy in cancer breast
    Durgesh Kumar Acharya, M.K.C.G. Medical College and Hospital, Berhampur, Ganjam, Orissa, The Antiseptic (1994): (91), 2, 67.


  9. Protection of fish liver with Liv.52 against cadmium intoxication – A histological study
    Rathore, H.S. and Naik, B.K., School of Studies of Zoology, Vikram University, Ujjain, Madhya Pradesh, Biologia (Lahore) (1994): (40), 1 and 2, 1.


  10. Down regulation of tumour necrosis factor activity in experimental hepatitis by a herbal formulation, Liv.52
    Roy, A., Soni, G.R., Kolhapure, R.M., National Institute of Virology, Pune, Maharashtra, and Karnik, U.R. and Patki, P.S., Departments of Pathology and Pharmacology, B.J. Medical College, Pune, Maharashtra, Indian Journal of Experimental Biology (1994): 32, 694.


  11. Hepatoprotective effect of Liv.52 against CCl4-induced lipid peroxidation in liver of rats
    Shivani Pandey, Gujrati, V.R., Shanker, K., Singh, N and Dhawan, K.N., Department of Pharmacology, K.G. Medical College, Lucknow, Uttar Pradesh, Indian Journal of Experimental Biology (1994): (32), Sep. 674.


  12. Protective effect of Liv.52 against anti-cancer chemotherapy in rats
    Yadav, S. and Yadav, R.,Department of Anatomy and Biochemistry, Indira Gandhi Medical College, Shimla, Jammu & Kashmir, India, Probe (1994): (XXXIII), 4, 323.


  13. Further studies on the protective effect of Liv.52 against CD-toxicity in mammalian system
    Rathore, H.S. and Nandi, K.K., School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Drugs (1992): (29), 4, 149.


  14. Effects of carbon tetrachloride and Liv.52 on the clearance rate of 131I-Rose Bengal in rat liver
    Dhawan, D., Goel, A., Department of Biophysics, Punjab University, Chandigarh, Haryana,and Karkara, K., Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, Haryana, AMPI Medical Physics Bulletin (1991): 16, (4), 27.


  15. Treatment of mice with a herbal preparation (Liv.52) reduces the frequency of radiation-induced chromosome damage in bone marrow
    Ganesh Chandra Jagetia and Ganapathi, N.G., Department of Radiobiology, Kasturba Medical College, Manipal, Karnataka, Mutation Research (1991): (253), 123.


  16. Preventive effects of Liv.52 on the activities of cytochrome P-450 and NADPH-dependent lipid peroxidation in the liver of carbon tetrachloride-intoxicated rats
    Goel, A. and Dhawan, D., Department of Biophysics, Punjab University, Chandigarh, Punjab, Medical Science Research (1991): (19), 113.


  17. Influence of Liv.52 on carbon tetrachloride-induced hepatotoxicity: A biochemical study
    Goel, A., Dhawan, D.K., Department of Biophysics, Punjab University, Chandigarh, and Gautam, C.S., Department of Pharmacology, PGIMER, Chandigarh, Punjab, Indian Journal of Pharmacology (1991): 23, 182.


  18. Role of Liv.52 in alopecia-induced by radiation and chemotherapy
    Harbans Lal Kapoor, Rajeev K. Seam and Sanjeev Sharma, Department of Radiation and Oncology, Indira Gandhi Medical College, Shimla, Himachal Pradesh, Probe (1990): (XXIX), 3, 215.


  19. Therapeutic use of Liv.52 in beryllium-induced reproductive toxicity in rats
    Mathur, S., Prakash, A.O. and Mathur, R. School of Studies in Zoology, Jiwaji University, Gwalior, India, Probe (1990): (XXIX), 4, 266.


  20. Recovery from beryllium-induced lesions after Liv.52 treatment
    Prakash, A.O., Mathur, S. and Mathur, R. School of Studies in Zoology, Jiwaji Universsity, Gwalior, India, Probe (1990): (XXIX), 4, 280.


  21. Protective role of Liv.52 against histological damage due to CdCl2 toxicity in the intestine of teleost fish
    Suresh Kothari, Bhaskar Reddy, P. and Rathore, H.S., School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Probe (1990): (XXIX), 3, 220.


  22. Effects of Liv.52 against cadmium chloride-induced changes on the activity of enzyme and mucosubstances in the intestine of mystus tengara (HAM)
    Bhasker Reddy, P. and Suresh Kothari, School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Environmental Risk Assessment (1989): Dec., 188.


  23. Effect of Liv.52 on carbon tetrachloride - Induced hepatotoxicity in rabbits
    Dhumal, M.S., Mane, I.H. and Patel, S.S., Department of Pharmacology, Rural Medical College, Loni, Shrirampur-Taluk, Ahmednagar-District, Maharashtra, Indian Journal of Pharmacology (1989): (21), 3, 96.


  24. Liv.52 protection against beryllium toxicity in female albino rats
    Mathur, R., Mathur, S. and Prakash, A.O., School of Studies in Zoology, Jiwaji University, Gwalior, Madhya Pradesh, Reproductive Toxicology (1989): (3), 249.


  25. Liv.52 protection against cadmium-induced histomorphological changes in mice spleen, duodenum and small intestine
    Rathore, H.S. and Hema Rawat (Miss.), School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Drugs (1989): (26), 10, 533.


  26. Rifampicin toxicity and Liv.52
    Purohit, S.D., Dilip K. Jain, Meena, R.C., Gupta, M.L., Gupta, P.R., Mathur, B.B., Gehlot, S.L. and Mehta, Y.R., Department of Respiratory Diseases and Tuberculosis, S.M.S. Medical College, Jaipur, Rajasthan, Probe (1988): (XXVII), 4, 261.


  27. Radioprotective effects of Liv.52 and tissue-reduced glutathione (GSH) in experimental rats
    Sarkar, S.R., Singh, L.R., Uniyal, B.P. and Bhatnagar, V.S., Institute of Nuclear Medicine and Allied Sciences, Probyn Road, Delhi, The Bombay, Maharashtra Hospital Journal (1988): 4, 41.


  28. Comparative efficacy of Liv.52 and andrographis paniculata, (Nees.) in experimental liver damage in rabbits
    Dwivedi, S.K., Sharma, M.C., Mukherjee, S.C., Jawaharlal and Pandey, N.N., Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, Indian Drugs (1987): (25), 1, 1.


  29. Effect of Liv.52 on SH-glutathione levels in carbon tetrachloride-induced liver damage
    Kulkarni, R.D., Regional Research Institute of Unani Medicine, Grant Medical College and J.J. Group of Hospitals, Bombay, Maharashtra, Probe (1987): (XXVII), 1, 19.


  30. Beryllium-induced haematological alterations and their response to Liv.52
    Mathur, R., Prakash, A.O. and Mathur, S., School of Studies in Zoology, Jiwaji University, Gwalior, Madhya Pradesh, Industrial Health (1987): 25, 131.


  31. Protection of mice liver with Liv.52 against cadmium intoxication
    Rathore, H.S. and Rita Verma, School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Drugs (1987): (25), 1, 11.


  32. Can Liv.52 protect mammalian kidney against toxic substances? – Results and possibilities
    Rathore, H.S., School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Drugs (1987): (25), 1, 7.


  33. Effect of Liv.52 on blood sugar in beryllium nitrate-exposed rats
    Seema Mathur, Prakash, A.O. and Mathur, R., School of Studies in Zoology, Jiwaji University, Gwalior, Madhya Pradesh, Current Science (1987): (56), 7, 322.


  34. Protective effect of Liv.52 against beryllium toxicity in rats
    Seema Mathur, Prakash, A.O. and Mathur, R., School of Studies in Zoology, Jiwaji University, Gwalior, Madhya Pradesh, Current Science (1986): (55), 18, 899.


  35. In vitro effect of an ayurvedic liver remedy on hepatic enzymes in carbon tetrachloride treated rats
    Piyush Bardhan, Sharma, S.K. and Garg, N.K., Central Drug Research Institute, Lucknow, Uttar Pradesh, Indian Journal of Medical Research (1985): (82), Oct., 359.


  36. Liv.52 protection against radiation-induced lesions in mammalian liver
    Saini, M.R., Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, and Saini, N., E.S.I. Hospital, Jaipur, Rajasthan, Radiobiology and Radiotherapy (1985): 26, 3, 379.


  37. Late effect of whole-body irradiation on the peripheral blood of mice and its modification by Liv.52
    Saini, M.R., Kumar, S., Uma Devi, P. and Saini, N., Department of Zoology, University of Rajasthan, Jaipur and Department of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan, Radiobiology and Radiotherapy (1985): (26), 4, 487.


  38. Survival of mice protected from lethal radiation by Liv.52
    Saini, M.R., Kumar, S., Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, and Saini, N., Department of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan, Probe (1984): (XXIII), 4, 209.


  39. Liv.52 protection against late effect of radiation on mammalian spleen
    Saini, M.R., Kumar, S., Jagetia, G.C., Department of Zoology, University of Rajasthan, Jaipur and Saini, N., Department of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan, Indian Drugs (1984): 9, 374.


  40. Effectiveness of Liv.52 against radiation sickness and dermatitis
    Saini, M.R., Sunil Kumar, Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, Jagetia, G.C., Department of Radiotherapy and Oncology, Kasturba Medical College Hospital, Manipal, Karnataka, and Navita Saini, Department of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan The Indian Practitioner (1984): December, 1133.


  41. Liver protection by Liv.52 in lipid peroxidation
    Soman, R.N., Bhatia General Hospital, Tardeo, Bombay, Maharashtra, Probe (1984): (XXIII), 2, 110.


  42. Effect of Liv.52 on carbon tetrachloride-induced changes in hepatic microsomal drug-metabolising enzymes of the rat
    Ira Thabrew, M., Godwin O. Emerole, Department of Biochemistry, and Subbarao, V.V., Department of Physiology, College of Medicine, University of Ibadan, Ibadan, Nigeria, Toxicology Letters (1982): 14, 183.


  43. Effect of Liv.52 on membrane lipids in carbon tetrachloride-induced hepatotoxicity in rats
    Alok Saxena, and Garg, N.K., Biochemistry Division, Central Drug Research Institute, Lucknow, Uttar Pradesh, Indian Journal of Experimental Biology (1981): (19), 859.


  44. Clinical evaluation of Liv.52 as an adjuvant in cancer cases getting large field irradiation with or without chemotherapy
    Krishnan Nair, M. and Chandrasekharan Nair, T., Department of Radiology and Cancer Institute, Medical College Hospital, Trivandrum, Kerala, Probe (1981): (XX), 4, 288.


  45. A case of radiation and drug-induced alopecia and premature greying cured with Liv.52
    Kamlakar Tripathi, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Capsule (1979): 6, 122.


  46. Effect of Liv.52 and carbon tetrachloride on the liver protein and nucleic acids
    Subbarao, V.V. and Gupta, M.L., Upgraded Department of Physiology, S.M.S. Medical College, Jaipur, Rajasthan, IRCS Medical Science (1979): 7, 499.


  47. Ultrastructural study on the regeneration of liver under the influence of Liv.52
    Prasad, G.C. and Gupta, R.C., Department of Shalya Shalakya, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Capsule (1978): 7, 146.


  48. An experimental evaluation of protective effects of some indigenous drugs on carbon tetrachloride-induced hepatotoxicity in mice and rats
    Singh, N. (Mrs.), Nath, R., Singh, D.R., Gupta, M.L. and Kohli, R.P., Department of Pharmacology and Therapeutics, K.G. Medical College, Lucknow, Uttar Pradesh, Quarterly Journal of Crude Drug Research (1978): (16), 1, 8.


  49. Effect of carbon tetrachloride and Liv.52 on liver microsomal protein, total protein and nucleic acids
    Subbarao, V.V. and Gupta, M.L., Upgraded Department of Physiology, S.M.S. Medical College, Jaipur, Rajasthan, The Indian Practitioner (1978): 11, 831.


  50. Report on the combination of a liver-stimulating preparation, Liv.52 with endoxan in the treatment of cancer
    Vaidya, M.D., Katra Hospital, Mandla, Madhya Pradesh, Probe (1978): (XVII), 2, 159.


  51. Changes in serum transaminases due to hepatotoxicity and the role of an indigenous hepatotonic Liv.52
    Subbarao, V.V., University of Tripoli, Tripoli, Libya, and Gupta, M.L., Upgraded Department of Physiology, S.M.S. Medical College, Jaipur, Rajasthan, Yugoslavia Physiologica Pharmacologica Acta (1976): 12.


  52. Clinical trial with Liv.52 in cases of malignant diseases treated at the barnard Institute of radiology
    Gajaraj, A. and Munuswamy, G., Barnard Institute of Radiology, Government General Hospital, Madras, Tamil Nadu, The Antiseptic (1972): (69), 8, 570.


  53. Effect of an indigenous drug on ICG (Indocyanine Green): Clearance and autoradiographic patterns in albino rats with experimentally induced hepatotoxicity
    Joglekar, G.V., Department of Pharmacology, B.J. Medical, Poona, Maharashtra and Leevy, C.M., Division of Liver and Nutrition, New Jersey College of Medicine and Dentistry, N.J. 07018, U.S.A., Journal of Indian Medical Profession (1970): 12, 7480.


  54. The protective action of Liv.52 against the hepatotoxicity of tetracycline in rats
    Anonymous, Department of Pharmacology, The Himalaya Drug Co., Bombay, Maharashtra, Probe (1967): (VI), 4, 169.


  55. Allyl alcohol-induced hepatotoxicity in rats and its protection by Liv.52
    Joglekar, G.V. and Balwani, J.H., Department of Pharmacology, B.J. Medical College, Poona, Maharashtra Journal of Experimental Medical Science (1967): 11, 7.


  56. Effect of Liv.52 on biochemical and functional abnormalities of the liver
    Qazi, I.H., Department of Pharmacology, The Himalaya Drug Co., Bombay, Maharashtra, Probe (1965): (V), 1, 1.


  57. Protection by indigenous drugs against hepatotoxic effects of carbon tetrachloride in mice
    Joglekar, G.V., Chitale, G.K. and Balwani, J.H., Departments of Pharmacology and Pathology, B.J. Medical College, Poona, Maharashtra, Acta Pharmacologica et Toxicologica (1963): 20, 73.


  58. Protection by Indigenous drugs against hepatotoxic effects of carbon tetrachloride – A long term study
    Karandikar, S.M., Joglekar, G.V., Chitale, G.K. and Balwani, J.H. Department of Pharmacology and Pathology, B.J. Medical College, Poona, India, Acta Pharmacologica et Toxicologica (1963): 20, 274-280.


  59. Effect of mercuric chloride on the survival, food-intake, body weight, histological and haematological changes in mice and their prevention with Liv.52
    Rathore, H.S. and Varghese, J., School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Journal of Occupational Health (Undated).


  60. Effect of a multiherbal drug on the distribution and excretion of mercury in mice treated with mercuric chloride
    Rathore, H.S. and Varghese, J., School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Drugs (Undated): (32), 6, 262.
   
As an adjuvant with hepatotoxic drugs  
  1. Effect of spirulina and Liv.52 on cadmium Indiuced toxicity in albino rats
    K Jeyaprakash & P Chinnaswamy Department of Biochemistry, Dr.N.G.P.Arts & Science College, Kovai Medical Center Research & Educational Trust, Coimbatore 641 014, India.

  2. Effect of hepatoprotective agent Liv.52 on nutrition parameters in hemodialysis patients
    Gordana Perunicic-Pekovic, Ljiljana Komadina, Steva Pljesa, Zorica Rasic-Milutinovic, Rodoljub Markovic, Department of Nephrology, University Hospital, Zemun-Belgrade and Natasa Milic, Institute of Statistics, Belgrade Medical School, Zemun-Belgrade, Medicine Update - Anniversary Issue, 2003, pp. 52-56.


  3. Protective effect of Liv.52 on Na+-K+-ATPase activity in paracetamol-induced hepatotoxicity
    Kala Suhas Kulkarni*, Md. Rafiq, Gopumadhavan, S., Venkataranganna, M.V., Madhumathi, B.G. and Mitra, S.K. R&D Center, The Himalaya Drug Company, Makali, Bangalore, India, Medicine Update (2002): (10), 5, 53-56.


  4. Therapeutic efficacy of Liv.52 in paracetamol induced hepatopathy in rabbits
    Anup Bhaumik and Sharma, M.C. Division of Experimental Medicine and Surgery, Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India, Indian Journal Veterinary Research (2002): (11), 1, 8-17.


  5. Hepatoprotective effect of Liv.52 on antitubercular drug-induced hepatotoxicity in rats
    Vijaya Padma, V, Suja, V. and Shyamala Devi, C.S. Department of Biochemistry, University of Madras, Guindy Campus, Madras, India. and Prema, Head-Department of Biochemistry, Tuberculosis Research Centre, Chetpet, Chennai, India, Fitoterapia (1998): (LXIX), 6, 520.


  6. Effect of phytotherapy on prevention and elimination of hepatotoxic reactions in patients with pulmonary tuberculosis and carriers of hepatitis B virus markers
    Galitsky, L.A., Barnaulov, O.D., Zaretskii, B.V., Malkov, M.I., Konenkov, S.I., Gol’m, N.P., Tomakov, V.S., Ogarkov, P.I. and Batskov, S.S. Military Academy of Medicine, Human Brain Institute of the Russian Academy of Sciences, Saint-Petersburg, Russia, Problems of Tuberculosis, (1997): 4, 35.


  7. Hepatoprotective role of Liv.52 against hepatitis-induced by antitubercular drugs
    Ashish Khare, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Probe (1992): (XXXI), 3, 260.


  8. Efficacy of Liv.52 and Geriforte as adjuvant in various carcinomas
    Durgesh Kumar Acharya, Regional Centre for Cancer Research and Treatment, Cuttack, Orissa, Probe (1986): (XXV), 3, 249.


  9. Role of Liv.52 in cyclophosphamide-induced alopecia
    Harbans Lal Kapoor, Seam, R.K. and Sanjiv Sharma, Department of Radiation Therapy and Oncology, Indira Gandhi Medical College, Simla, Himachal Pradesh, Probe (1986): (XXV), 4, 344.


  10. Hepatoprotective role of indigenous drug Liv.52 in lepromatous leprosy
    Pranesh Nigam and Mukhija, R.D., B.R.D. Medical College, Gorakhpur, Dayal, S.G., Government Medical College, Jammu-Tawi, Goyal, B.M. and Joshi, L.D., M.L.B. Medical College, Jhansi, Madhya Pradesh, Hansenlogia Internationalis, Brazil (1982): 7, 1, 36.


  11. Experience with Liv.52 as an adjuvant to anti-tubercular treatment
    Vinod Kumar Gupta, The Sincere Dispensary and Nursing Home, Rori Bazar, Sirsa, Haryana, Capsule (1980): 6, 122.


  12. Effect of Liv.52 on hepatic enzymes
    Alok Saxena and Garg, N.K., Division of Biochemistry, Central Drug Research Institute, Lucknow, Uttar Pradesh, Indian Journal of Experimental Biology (1979): 7, 662.


  13. The effect of Liv.52 on liver functions of tubercular patients receiving second line anti-tubercular drugs
    Brij Kishore, Hazra, D.U., Sachan, A.S., Agrawal, B.M., Bharadwaj, Ashok Kumar and Mehrotra, M.M.N., Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, Probe (1978): (XVII), 2, 125.


  14. Some observations with Liv.52 therapy in cases of malignancy
    Harish Kulkarni, R.S.T. Cancer Centre, Nagpur, Maharashtra, Probe (1978): (XVII), 3, 233.


  15. Effect of an indigenous (herbal) drug Liv.52 on the hepatic damage caused by oral contraceptives – A biochemical (enzymatic) approach
    Khuteta, K.P., Upgraded Department of Physiology and Biochemistry, S.M.S. Medical College, Jaipur, Rajasthan, Probe (1978): (XVII), 2, 115.


  16. Leprous hepatitis: Clinico-pathological study and therapeutic efficacy of Liv.52
    Pranesh Nigam, Dayal, S.G., Goyal, B.M., Nimkhedakar, K., Joshi, L.D. and Samuel K.C., M.L.B. Medical College, Jhansi, Uttar Pradesh, Leprosy in India (1978): (50), 2, 185.


  17. Tissue culture and electron microscopic study on regeneration of liver with Liv.52
    Prasad, G.C., Department of Shalya and Surgical Research Laboratory, Institute of Medical Science, Banaras Hindu University, Varanasi, Uttar Pradesh,Capsule (1978): 6, 122.


  18. Liv.52-induced modification of barbiturate hypnosis in albino rats
    Joglekar, G.V., Saraf, A.P., Moholkar, A.L. and Shirole, M.V. (Miss.), Department of Pharmacology, B.J. Medical College, Pune, Maharashtra, Maharashtra Medical Journal (1977): (XXIV), 2, 67.


  19. Paracetamol-induced hepatotoxicity and the protective effect of Liv.52
    Mujumdar, S.M. and Kulkarni, R.D., Department of Pharmacology, B.J. Medical College, Pune, Maharashtra, The Indian Practitioner (1977): (XXX), November, 479.


  20. Anorexia in osteoarticular tuberculosis
    Dabral, P.K., Srivastava, M.K. and Madhu Dabral (Mrs.), M.L.B. Medical College, Jhansi, Madhya Pradesh, Probe (1976): (XV), 3, 199.


  21. Electron microscopic study on the effect of Liv.52 on carbon tetrachloride treated liver
    Prasad, G.C., Department Shalya and Surgical Research Laboratory, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Journal of Research in Indian Medicine, Yoga and Homeopathy (1976): 4, 38.


  22. Role of Liv.52 in hepatomegaly associated with childhood tuberculosis (A clinico-histopathological study)
    Kumar, P. and Shishupal Ram, Department of Paediatrics, Patna Medical College Hospital, Patna, Bihar, The Indian Practitioner (1975): 10, 535.


  23. Place of Liv.52 as an adjuvant to chemotherapy of malignant diseases
    Munuswamy, G. and Gajraj, A., Barnard Institute of Radiology and Cancer, Government General Hospital and Madras Medical College, Madras, Tamil Nadu, Probe (1975): (XV), 1, 1.


  24. Effect of Liv.52 on the liver in vitro
    Prasad, G.C., Department of Shalya and Surgical Research Laboratory, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Journal of Research in Indian Medicine (1975): 4, 15.


  25. Effect of Liv.52 on regeneration of liver cells in tissue culture – A preliminary report
    Prasad, G.C., Department of Shalya Shalakya and Surgical Research Laboratory, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Journal of Research in Indian Medicine (1974): (9), 2, 60.


  26. Liv.52 as adjuvant therapy with hepatotoxic and cytotoxic drugs
    Vaidya, M.D., Katra Hospital, Mandla, Madhya Pradesh, Probe (1974): (XIII), 2, 73.


  27. Liv.52 improves thioacetazone tolerance
    Major Jayaram, C.N., T.B. Sanatorium, Austinpatti, Madurai, Tamil Nadu, Probe (1969): (VIII), 4, 160.
   
Miscellaneous  
  1. Effect of Liv.52 in digestive disorders among children
    Khrushcheva, N.A. and Safronova, L.E., State Medical Academy based in Ural, Regional Children's Clinical Hospital, Ekaterinburg, Russia, Capsule (2002): (XLI), 4, January / March.


  2. Use of hepatoprotective agents in hepatomegaly syndrome in children: An experience with Liv.52 Syrup
    Otilia Marginean, MD, PhD, Ioana Micle, MD, PhD, Maria Lesovici, MD, PhD, Pediatric Hospital "Louis Turcanu", Timisoara, Romania, Raluca Balean, MD, Budiu Ioana, MD, County Hospital Nr. 1, Timisoara, Romania, and Edited by: Kala Suhas Kulkarni, MD, MCPS Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, Karnataka, India, Medicine Update (2002): (10), 8, 57.


  3. Physiological Icterus of the newborn and the role of Liv.52
    Goel, S.P., Lecturer, Department of Pediatrics, Garg, B.K., Professor and Head of the Department of Pediatrics Sharma, D.K., Professor in the Department of Pediatrics, Upadhyay, V.K., Lecturer in the Department of Pediatrics, L.L.R.M. Medical College, Meerut, India, Probe (1994): (XXXIV), 1, 45.


  4. Prevention of mercuric chloride-induced histopathological changes in the small intestine of mice with Liv.52
    Johnson, V. and Rathore, H.S., Cell Biology Unit, School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Journal of Medical Sciences (1994): (48), 11, 253.


  5. Chemopreventive action of Liv.52 on DMBA-induced papillomagenesis in skin of mice
    Ritu Prashar and Ashok Kumar, Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, Indian Journal of Experimental Biology (1994): (32), Sep., 643.


  6. Evaluation of the role of Liv.52 treatment in swiss albino mice during pre- and post-natal development
    Saini, M.R., Sharma, K. and Kumar, A., Radiation Biology Laboratory, University of Rajasthan, Jaipur, India, Probe (1994): (XXXIII), 4, 343.


  7. Cytogenetic effects of Liv.52 on the male germline cells of poekilocerus pictus (Acrididae: Orthoptera)
    Edward Gururaj, M. and Uma, O., Department of Studies in Zoology, University of Mysore, Mysore, Karnataka, Journal of Mysore University (1993): (33), 181.


  8. Role of Liv.52 and Geriforte as general metabolic tonics in drug addicts
    Jain, N.C., Government Rajindera Medical College and Hospital, Patiala, Singal, R.P., Dayanand Hospital, Ludhiana, Punjab, and Shahi, S.R., S.S.M.D. Ayurvedic College and Hospital, Moga, Punjab, Probe (1992): (XXXII), 1, 32.


  9. Absence of teratogenic effect of Liv.52 in albino rats
    Singh, N., Verma, P. and Mishra, N., Upgraded Department of Pharmacology and Therapeutics, K.G. Medical College, Lucknow, Uttar Pradesh, Journal of Biological and Chemical Research (1990): (9), 445.


  10. Inhibition of clastogenic effect of radiation by Liv.52 in the bone marrow of mice
    Ganesh Chandra Jagetia and Ganapathi, N.G., Department of Radiobiology, Kasturba Medical College, Manipal, Karnataka, Mutation Research (1989): (224), 4, 507.


  11. Lack of teratogenicity of Liv.52
    Chauhan, B.L., Gurjar, P.A. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, Probe (1988): (XXVIII), 1, 36.


  12. Liv.52 protection against radiation-induced abnormalities on mammalian prenatal development
    Saini, M.R., Kumar, S., Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, and Saini, N., Department of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan, Radiobiology and Radiotherapy (1985): (26), 3, 385.


  13. The treatment of non-suppurative hepatic amoebiasis with Liv.52 as an adjuvant to antiamoebic drugs
    Bose, S.L. and Rout, A.K., Department of Medicine, S.C.B. Medical College, Cuttack, Orissa, Indian Medical Journal (1983): 1, 3.


  14. Role of Liv.52 in the treatment of pityriasis alba
    Chakraborty, A.K., G.T. Road, Kalitala, Serampore, West Bengal, Capsule (1983): 1, 9.


  15. Liv.52 in burns cases
    Malla, C.N. and Surinder Singh, Medical College and H.M.H.S. Hospital, Srinagar, Jammu and Kashmir, Probe (1982): (XXII), 1, 24.


  16. Clinical trial of Liv.52 in burns
    Parangusa Das, R.A., Vijayalakshmi, B. and Subhashini, M.,Victoria Hospital, Bangalore, Karnataka, Probe (1982): (XXI), 3, 192.


  17. Role of Liv.52 in psychiatric illness
    Rustom N. Burjorjee, Calcutta Medical Centre, London Street, Calcutta, West Bengal, Capsule (1982): 5, 98.


  18. A case study on Liv.52 an adjuvant in diabetes mellitus
    Sinha, A.K., P.T.P.S. Hospital, Patralu, District, Hazaribagh, Bihar, Capsule (1982): 8, 178.


  19. Effect of Liv.52 on liver lipids
    Alok Saxena, Sharma, S.K. and Garg, N.K., Department of Biochemistry, Central Drug Research Institute, Lucknow, Uttar Pradesh, Indian Journal of Experimental Biology (1980): 11, 1330.


  20. Potentiation of barbiturate hypnosis in rats by Liv.52
    Dhume, V.G., Goa Medical College, Panaji, Goa, and Bijlani, C.J., T.N. Medical College, Bombay, Maharashtra, The Clinician (1979): (43), 2, 59.


  21. Evaluation of Liv.52 in the treatment of jaundice with pregnancy
    Arun Kumar Mitra and Abhik De, Calcutta Medical College, West Bengal, Probe (1978): (XVII), 2, 143.


  22. Liv.52 in herpes-progenitalis
    Iswar Tanwani, Howrah Road, Deolali Cantonment, Nasik District, Maharashtra, Journal of National Integrated Medical Association (1976): (18), 3, 98.


  23. Effect of Liv.52 on serum lipids in normal and patients suffering from ischaemic heart disease
    Rao, C.R. and Subba Rao, A., Bowring and Lady Curzon Hospital, Postgraduate and Research Institute, Bangalore, Karnataka, Probe (1975): (XIV), 3, 177.


  24. Radioactive Rose Bengal test of liver function – A preliminary report of Liv.52 trial
    Rajagopal, K.R., Radio-Isotope Department, Barnard Institute of Radiology, Government General Hospital, Madras, Tamil Nadu, Probe (1974): (XIV), 1, 50.


  25. A clinical study of the therapeutic efficacy of Liv.52 as an adjuvant in the treatment of hepatic amoebiasis
    Sethi, J.P. and Suresh Meratwal, Department of Medicine, S.M.S. Medical College and Attached Hospital, Jaipur, Rajasthan, Probe (1973): (XII), 3, 129.


  26. Gastrointestinal allergy treated with Liv.52 – A case report
    Tripathi, A.R., Department of Forensic Medicine, Institute of Medical Services, Banaras Hindu University, Varanasi, Uttar Pradesh, Capsule (1973): June/July, 30.


  27. Liv.52 in dermatology
    Behl, P.N., Skin Institute, Delhi, Probe (1972): (XI), 2, 100.


  28. Therapy of toxaemias of pregnancy
    Narone, J.N., and Raj Narone (Mrs.), Department of Gynaecology and Obstetrics, Patna Medical College, Patna, Bihar, Probe (1972): (XI), 2, 120.


  29. Some studies on physiological jaundice of the new-born
    Srivastava, J.R., Bhalla, J.N. and Arora, A., G.S.V.M. Medical College, Kanpur, Uttar Pradesh, Probe (1972): (XII), 1, 4.


  30. Liv.52 in vitiligo
    Punshi, S.K. Consultant Dermatologist and Abroal, S.K., Amravati, M.S., Probe (1970): (X), 1, 12.


  31. Studies with Liv.52
    Lala Surajnandan Prasad, Department of Paediatrics, Patna University, Patna, Bihar and Devendra Tripathy, Hospital for Children, Patna Medical College Hospital, Patna, Bihar, Probe (1969): (IX), 1, 1.


  32. Metabolic effect of an indigenous compound on sportsmen
    Mathur, D.N., The National Institute of Sports, Patiala, Punjab, Probe (1969): (VIII), 4, 144.


  33. Liv.52 in general practice
    Shah, N.B., Malegaon City, Nasik, Maharashtra, Probe (1969): (VIII), 3, 101.


  34. A clinical study – Physiological jaundice in neonates
    Chafekar, V.D., Annapoornabai Maternity and Nursing Home, Gadag, Karnataka, Probe (1968): (VII), 3, 85.


  35. Observations on Liv.52
    Patrao, S., B.Y.L. Nair Hospital and T.N. Medical College, Bombay, Maharashtra, Journal of Indian Medical Profession (1957): 8, 1878.


  36. Ascitis due to liver deficiency treated with an indigenous drug
    Sule, C.R., Sathe, P.M., Koshy, M.C. and Desphande, M.S., The Indian Practitioner (1956): (IX), 4, 357.
     
  FAQs   |   Glossary   |   Sitemap   |   Privacy Policy   |   Terms of Use  
  Copyright © 2002 The Himalaya Drug Company.